NDC properties for NDC 9 72606-030
NDC item 72606003001
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-01 |
| NDC Item | 72606003001 |
| packaging | 1 SYRINGE in 1 CARTON (72606-030-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
NDC item 72606003002
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-02 |
| NDC Item | 72606003002 |
| packaging | 2 SYRINGE in 1 CARTON (72606-030-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
NDC item 72606003003
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-03 |
| NDC Item | 72606003003 |
| packaging | 4 SYRINGE in 1 CARTON (72606-030-03) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
NDC item 72606003004
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-04 |
| NDC Item | 72606003004 |
| packaging | 6 SYRINGE in 1 CARTON (72606-030-04) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
NDC item 72606003005
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-05 |
| NDC Item | 72606003005 |
| packaging | 1 SYRINGE in 1 CARTON (72606-030-05) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
NDC item 72606003006
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-06 |
| NDC Item | 72606003006 |
| packaging | 2 SYRINGE in 1 CARTON (72606-030-06) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
NDC item 72606003007
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-07 |
| NDC Item | 72606003007 |
| packaging | 4 SYRINGE in 1 CARTON (72606-030-07) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
NDC item 72606003008
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-08 |
| NDC Item | 72606003008 |
| packaging | 6 SYRINGE in 1 CARTON (72606-030-08) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |